Skip to main content
The Inyo Register
Click for weather forecast
Place a Classified Ad
View Full List
Dow Jones Industrial Average
Standard & Poors 500
New York Composite
Official Closing Price
Updated: 3:58 PM EDT, Sep 23, 2021
Add to My Watchlist
Stories about Endocan Corp
Stocks That Hit 52-Week Lows On Thursday
January 30, 2020
Thursday's morning session saw 179 companies set new 52-week lows. Areas of Interest: Exxon Mobil(NYSE: XOM)was ...
Stocks That Hit 52-Week Lows On Tuesday
November 05, 2019
Before 10 a.m. ET Tuesday, 78 stocks hit new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to ...
Stocks That Hit 52-Week Lows On Wednesday
August 21, 2019
On Wednesday morning, 85 companies hit new 52-week lows. Areas of Interest: Japan Tobacco (OTC: JAPAF) is the largest company ...
Endo Stock Surges 17% Following Settlement Agreement
August 20, 2019
micro small cap
top pharmaceutical companies
Endo To Enter A Year Of Recovery Following FDA Request To Pull Opana ER Off The Market
June 09, 2017
Shares of Endo International plc - Ordinary Shares (NASDAQ: ENDP) were trading lower by more than 10 percent Friday morning in reaction ...
Could Trump Tax Cut Plans, Republican Congress Spur Biotech M&A?
November 10, 2016
Donald Trump could create an M&A-friendly tax scenario, prodding more acquisitions from the small- and mid-cap biotech pool.
Investor's Business Daily
The Market In 5 Minutes: Jobs Numbers, Big Earnings Close The Week
November 04, 2016
Macro Focus Futures for the Dow Jones Industrial Average dropped 20 points to 17,831.00, while the Standard & Poor’s ...
Endo to pay $25M for nasal testosterone replacement therapy
November 24, 2014
Endo International made a bigger push into the testosterone replacement therapy market Monday by agreeing to acquire the rights to Natesto for $25 million...
Better the 2nd time around: Auxilium accepts Endo's $2.6B buyout offer
October 09, 2014
After rebuffing an unsolicited takeover attempt last month, Auxilium Pharmaceuticals Inc. decided to accept a revised buyout offer from Endo International in a deal involving two biopharmaceutical...
Endo reaches deal to resolve remaining vaginal mesh product claims
October 01, 2014
Endo International has reached master settlement agreements with several of the remaining leading plaintiffs’ law firms to resolve remaining claims relating to vaginal mesh products sold by its...
Endo's $2.2B offer for Auxilium is not good enough, board says
September 22, 2014
Auxilium Pharmaceuticals Inc.’s board of directors unanimously reaffirmed its position Monday that the company should continue moving forward with its plans to merge with QLT Inc...
Endo makes unsolicited $2.2B offer for Auxilium
September 17, 2014
Endo International has made a $2.2 billion offer to buy Auxilium Pharmaceuticals in a deal that would join together two of the region's largest life sciences companies...
Endo launches generic testosterone replacement gel
September 08, 2014
Endo International on Monday launched a generic version of its testosterone gel Fortesta, a treatment for adult males diagnosed with hypogonadism — a condition where the body's sex glands produce...
Endo Reaches $830M Settlement on Majority of AMS Litigation Cases
April 30, 2014
Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that it has reached agreements in principle with several leading ...
Markets Flat As Greece Deals With Debt
January 11, 2012
MarketMinute » Market Updates
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Terms and Conditions
Copyright © 2015 The Inyo Register | 1180 N Main St Ste 108 | Bishop, CA, 72104 | (760) 873-3535
All property rights for the entire contents of this publication shall be the property of The Inyo Register.
No part hereof may be reproduced without prior written consent.